ArticleTherapeutic advances in gastroenterology2026
Comments on "Prevalence, patient characteristics and outcomes of high-dose upadacitinib in inflammatory bowel disease".
Aliza Altaf et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.